We observed that anti-TNFR2 treatment showed a strong antitumor effect by significantly suppressing tumor growth as compared with isotype IgG control, and two mice in the treatment group reached complete response (CR) (Figure 5A). Here, TNFRSF1B is linked to neoplasm.